LFCR logo

Lifecore Biomedical, Inc. (LFCR)

Profile

Full Name

Lifecore Biomedical, Inc.

Ticker

NASDAQ: LFCR

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

February 15, 1996

Indexes

Not included

Website

https://www.lifecore.com

Employees

524

Key Details

Price

$7.28(-0.14%)

Market cap

$272.33M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$128.87M(+0.47% YoY)

Annual EPS

-$1.27(-496.88% YoY)

PE ratio

-

Next earnings date

Oct 3, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.28
    LFCR price is $7.28

    30-Day Relative Volume

    1.31
    LFCR 30-day relative volume is 1.31

    Price Performance

    Price Today change

    -0.14%
    LFCR price is down -0.14% today

    Price YTD change

    -2.02%
    LFCR price is down -2.02% since January 1st

    Price 1-year change

    +53.26%
    LFCR price is up +53.26% year-on-year

    Price 3-year change

    -28.28%
    LFCR price is down -28.28% over the past 3 years

    Price Range

    Price All-time high

    $20.75
    LFCR price is currently -64.92% below its historical high of $20.75

    Price 3-year low

    $1.52
    LFCR price is currently +378.95% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $272.33M
    LFCR market capitalization is $272.33 million

    Market cap 3-year change

    -9.33%
    LFCR market capitalization is down -9.33% over the past 3 years

    Market cap All-time high

    $429.25M
    LFCR market capitalization is currently -36.56% below its historical high of $429.25 million

    Market cap sector rank

    55%
    LFCR market capitalization is higher than 55% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +21.07%
    LFCR shares outstanding is up +21.07% year-on-year

    Shares Outstanding 3-Year Change

    +26.41%
    LFCR shares outstanding is up +26.41% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.76
    LFCR beta is 1.76

    200-day SMA

    $6.88
    LFCR price is currently +5.84% above its 200-day simple moving average

    50-day SMA

    $7.62
    LFCR price is currently -4.42% below its 50-day simple moving average

    RSI

    45.18
    LFCR 14-day relative strength index is 45.18

    Volume

    1.31
    LFCR 30-day relative volume is 1.31

    ATR

    $0.39
    LFCR average true range is $0.39

    10-day Historical Volatility

    41.79%
    LFCR 10-day historical volatility is 41.79%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $128.87M
    LFCR annual revenue is $128.87 million

    Revenue Analysts estimate

    $132.81M
    LFCR annual revenue is currently -2.97% lower than the consensus analysts' forecast

    Revenue 1-year change

    +0.47%
    LFCR annual revenue is up +0.47% year-on-year

    Revenue Sector rank

    70.22%
    LFCR annual revenue is higher than 70.22% of companies in Healthcare sector

    EPS

    EPS

    -$1.27
    LFCR annual earnings per share is -$1.27

    EPS Analysts estimate

    -$0.64
    LFCR annual earnings per share is currently +98.44% higher than the consensus analysts' forecast

    EPS 1-year change

    -496.88%
    LFCR annual earnings per share is down -496.88% year-on-year

    EPS Sector rank

    46.55%
    LFCR annual earnings per share is higher than 46.55% of companies in Healthcare sector

    Profit

    Gross profit

    $40.30M
    LFCR annual gross profit is $40.30 million

    Gross margin

    31.27%
    LFCR annual gross profit margin is 31.27%

    Operating profit

    -$12.01M
    LFCR annual operating income is -$12.01 million

    Operating margin

    -9.32%
    LFCR annual operating profit margin is -9.32%

    Net income

    -$38.72M
    LFCR annual net profit is -$38.72 million

    Net margin

    -30.04%
    LFCR annual net profit margin is -30.04%

    Expenses

    Total expenses

    $140.87M
    LFCR annual total expenses is $140.87 million

    Operating expenses

    $52.30M
    LFCR annual total operating expenses is $52.30 million

    Cost of goods sold

    $88.57M
    LFCR annual cost of goods sold is $88.57 million

    Selling, general & administrative expenses

    $44.05M
    LFCR annual SGA is $44.05 million

    Depreciation and amortization

    $8.03M
    LFCR annual depreciation & amortization is $8.03 million

    Interest expense

    $0.00
    LFCR annual interest expense is $0.00

    Income tax

    $43.00K
    LFCR annual income tax is $43.00 thousand

    EBIT & EBITDA

    EBIT

    -$16.84M
    LFCR annual earnings before interest & taxes is -$16.84 million

    EBITDA

    -$8.81M
    LFCR annual EBITDA is -$8.81 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $239.34M
    LFCR annual total assets is $239.34 million

    Non current assets

    $153.66M
    LFCR annual long term assets is $153.66 million

    Current assets

    $85.68M
    LFCR annual total current assets is $85.68 million

    Cash and cash equivalents

    $8.27M
    LFCR annual cash & cash equivalents is $8.27 million

    Accounts receivable

    $43.67M
    LFCR annual accounts receivable is $43.67 million

    Inventory

    $32.29M
    LFCR annual inventory is $32.29 million

    Liabilities

    Total liabilities

    $191.91M
    LFCR annual total liabilities is $191.91 million

    Long term liabilities

    $207.83M
    LFCR annual total long term liabilities is $207.83 million

    Current liabilities

    $30.18M
    LFCR annual total current liabilities is $30.18 million

    Accounts payable

    $8.22M
    LFCR annual accounts payable is $8.22 million

    Debt

    Total debt

    $132.17M
    LFCR annual total debt is $132.17 million

    Total debt 1-year change

    +1.39%
    LFCR annual total debt is up +1.39% year-on-year

    Long term debt

    $128.34M
    LFCR annual long term debt is $128.34 million

    Short term debt

    $3.82M
    LFCR annual short term debt is $3.82 million

    Equity & Capital

    Shareholders equity

    $47.43M
    LFCR annual stockholders equity is $47.43 million

    Book value

    $1.34M
    LFCR annual book value is $1.34 million

    Retained earnings

    -$205.24M
    LFCR annual retained earnings is -$205.24 million

    Working capital

    $55.50M
    LFCR annual working capital is $55.50 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$206.00K
    LFCR annual cash flow from operations is -$206.00 thousand

    Cash from operations 1-year change

    -180.16%
    LFCR annual cash flow from operations is down -180.16% year-on-year

    Cash from investing

    -$6.42M
    LFCR annual cash flow from investing activities is -$6.42 million

    Cash from investing 1-year change

    +65.13%
    LFCR annual cash flow from investing activities is up +65.13% year-on-year

    Cash from financing

    $6.42M
    LFCR annual cash flow from financing activities is $6.42 million

    Cash from financing 1-year change

    -14.45%
    LFCR annual cash flow from financing activities is down -14.45% year-on-year

    CAPEX

    CAPEX

    $13.41M
    LFCR annual capital expenditures is $13.41 million

    CAPEX 1-year change

    -27.07%
    LFCR annual capital expenditures is down -27.07% year-on-year

    Free Cash Flow

    Free cash flow

    -$13.62M
    LFCR annual free cash flow is -$13.62 million

    Free cash flow 1-year change

    +24.9%
    LFCR annual free cash flow is up +24.9% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    31.27%
    LFCR annual gross profit margin is 31.27%

    Operating margin

    -9.32%
    LFCR annual operating profit margin is -9.32%

    Net margin

    -30.04%
    LFCR annual net profit margin is -30.04%

    ROA & ROE

    ROA

    -15.09%
    LFCR annual return on assets is -15.09%

    ROE

    -76.41%
    LFCR annual return on equity is -76.41%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    LFCR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    LFCR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    203.85
    LFCR price to book ratio is 203.85

    PB ratio Sector rank

    99.66%
    LFCR price to book ratio is higher than 99.66% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.11
    LFCR price to sales ratio is 2.11

    PS ratio Sector rank

    36.72%
    LFCR price to sales ratio is higher than 36.72% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $396.23M
    LFCR enterprise value is $396.23 million

    Enterprise value Sector rank

    63.26%
    LFCR enterprise value is higher than 63.26% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -98.49
    LFCR EV/EBITDA is -98.49

    EV/EBITDA Sector rank

    1.52%
    LFCR EV/EBITDA is higher than 1.52% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.84
    LFCR annual current ratio is 2.84

    Quick ratio

    1.77
    LFCR annual quick ratio is 1.77

    Leverage

    Debt to equity

    97.63
    LFCR annual debt to equity ratio is 97.63

    Interest coverage ratio

    -
    LFCR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    LFCR piotroski f-score is 3

    Altman Z-Score

    0.24
    LFCR altman z-score is 0.24

    Analyst ratings

    Recent major analysts updates

    Sep 4, 25 Keybanc
    Sector Weight
    May 21, 25 William Blair
    Outperform
    Jan 3, 25 Stephens & Co.
    Equal-Weight
    Nov 22, 24 Craig-Hallum
    Buy
    Sep 5, 24 Craig-Hallum
    Buy
    Aug 28, 24 Barrington Research
    Market Perform
    Sep 1, 23 Stephens & Co.
    Equal-Weight
    Sep 1, 23 Barrington Research
    Outperform
    Jun 2, 23 Barrington Research
    Outperform
    May 24, 23 Barrington Research
    Outperform

    Institutional Ownership

    Screeners with LFCR included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    • What is the ticker symbol for Lifecore Biomedical, Inc.?
    • Does Lifecore Biomedical, Inc. pay dividends?
    • What sector is Lifecore Biomedical, Inc. in?
    • What industry is Lifecore Biomedical, Inc. in?
    • What country is Lifecore Biomedical, Inc. based in?
    • When did Lifecore Biomedical, Inc. go public?
    • Is Lifecore Biomedical, Inc. in the S&P 500?
    • Is Lifecore Biomedical, Inc. in the NASDAQ 100?
    • Is Lifecore Biomedical, Inc. in the Dow Jones?
    • When was Lifecore Biomedical, Inc.'s last earnings report?
    • When does Lifecore Biomedical, Inc. report earnings?

    What is the ticker symbol for Lifecore Biomedical, Inc.?

    The ticker symbol for Lifecore Biomedical, Inc. is NASDAQ:LFCR

    Does Lifecore Biomedical, Inc. pay dividends?

    No, Lifecore Biomedical, Inc. does not pay dividends

    What sector is Lifecore Biomedical, Inc. in?

    Lifecore Biomedical, Inc. is in the Healthcare sector

    What industry is Lifecore Biomedical, Inc. in?

    Lifecore Biomedical, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Lifecore Biomedical, Inc. based in?

    Lifecore Biomedical, Inc. is headquartered in United States

    When did Lifecore Biomedical, Inc. go public?

    Lifecore Biomedical, Inc.'s initial public offering (IPO) was on February 15, 1996

    Is Lifecore Biomedical, Inc. in the S&P 500?

    No, Lifecore Biomedical, Inc. is not included in the S&P 500 index

    Is Lifecore Biomedical, Inc. in the NASDAQ 100?

    No, Lifecore Biomedical, Inc. is not included in the NASDAQ 100 index

    Is Lifecore Biomedical, Inc. in the Dow Jones?

    No, Lifecore Biomedical, Inc. is not included in the Dow Jones index

    When was Lifecore Biomedical, Inc.'s last earnings report?

    Lifecore Biomedical, Inc.'s most recent earnings report was on April 3, 2025

    When does Lifecore Biomedical, Inc. report earnings?

    The next expected earnings date for Lifecore Biomedical, Inc. is October 3, 2025
    On this page